CrystalGenomics Inc (083790) — Capital Reinvestment Ratio

Latest as of June 2018: 0.01x

CrystalGenomics Inc (083790) has a Capital Reinvestment Ratio of 0.01x as of June 2018, meaning it reinvests 0% of its operating cash flow (₩4.21 Billion) in capital expenditures (₩22.51 Million). See 083790 net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

₩4.21 Billion

KRW

Capital Expenditures

₩22.51 Million

KRW

Data as of

Jun 2018

Most recent filing

CrystalGenomics Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks CrystalGenomics Inc's Capital Reinvestment Ratio across 1 annual periods. Check CrystalGenomics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for CrystalGenomics Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for CrystalGenomics Inc from 2017 to 2017. For live market cap and broader valuation context, see 083790 stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2017	6.57x	₩1.63 Billion	₩10.74 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow